• Japanese
  • Korean
  • Chinese
Cover Image

Digital Pathology Systems

This report analyzes the worldwide markets for Digital Pathology Systems in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 46 companies including many key and niche players such as 3DHISTECH Ltd., AccelPath, Inc., Apollo PACS, Inc., Carl Zeiss MicroImaging GmbH, Corista LLC, Definiens AG, DigiPath Inc., Flagship Biosciences, LLC, Koninklijke Philips Electronics N.V., Leica Microsystems GmbH, Aperio Technologies, Inc., MikroScan Technologies, Inc., Olympus America, Inc., Omnyx, LLC, Pixcelldata Ltd., Ventana Medical Systems, Inc., BioImagene, Inc., and VMscope GmbH. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. ECUTIVE SUMMARY

1. OUTLOOK

  • A Prelude
  • Current & Future Analysis
  • Key Trends and Drivers
  • Challenges Ahead for Digital Pathology Systems

2. INDUSTRY OVERVIEW

  • Traditional Pathology Workflow - A Cumbersome Process Laced with Issues
  • The Evolution of Digital Pathology Systems
  • Digital Pathology Products and Procedures
  • Digital Pathology as a Service Eludes Cost-based Issues
  • Applications of Digital Pathology and the Need for a Management System
  • Digital Pathology in Treatment of Cancer and Other Diseases
  • Digital Pathology in the Clinical Research Scenario
  • Telepathology Expected to Pave Way for Pathology Outsourcing to Developing Nations
  • Cloud Hosting and Web-based Applications Offer Cost-Effective Digital Pathology Options
  • A Review of Information Archival and Retrieval in Digital Pathology
  • Storage and Interoperability
  • Location and Internal Communication
  • Systems and Data Reliability
  • Image Life-Cycle Management
  • IT infrastructure and Management Costs
  • Factors Affecting Information Archival

3. COMPETITION

  • Leading Players
    • Table 1: Leading Players in the Global Digital Pathology Systems Market (2012): Percentage Breakdown of Dollar Sales for Leica/Aperio, Ventana, Olympus and Others (includes corresponding Graph/Chart)
  • Consolidation Rife in the Digital Pathology Space
  • Leica's Acquisition of Aperio - The Underlying Rationale

4. PRODUCT OVERVIEW

  • An Introduction to Pathology
  • What is Digital Pathology?
  • Benefits of Digital Pathology
  • Access to Digital Slide Images Anytime Anywhere
  • Digital Pathology Management Systems
  • Easier Analysis and Retrieval of Digital Images
  • Applications
  • Remote Reviewing
  • Digital-Assisted Mathematical Analysis
  • Data Storage
  • Telepathology
    • Static Telepathology
    • Dynamic Telepathology
    • Hybrid Telepathology
  • Bio-banking
  • Multinational Integration
  • Tissue Microarray Analysis

5. PRODUCT INTRODUCTIONS/INNOVATIONS

  • Ventana Medical Systems Launches iScan HT Slide Scanner
  • Aperio Technologies Introduces Release 11.0 of Digital Pathology System
  • Omnyx Showcases Upcoming Integrated Digital Pathology Solution
  • Pixcelldata Unveils Collibio Desktop Version
  • Carl Zeiss MicroImaging Launches LSM 700 Microscope
  • Agfa Healthcare Unveils Integrated Digital Pathology Solution
  • Leica Microsystems Expands Capabilities of Leica SCN400 and SCN400 F Scanners
  • Omnyx Unveils Omnyx™ VL4 Scanner to Beta Consumers
  • Leica Microsystems Launches Total Digital Pathology Solution
  • Definiens® Unveils Quantitative Digital Pathology Portfolio
  • Aperio Technologies Introduces ScanScope AT Pathology Slide Scanner
  • MikroScan Technologies Unveils MikroScan D2 Slide Imaging Scanner
  • Caliper® Life Sciences Introduces Vectra™ 2 with AQUA Technology for Quantification of Protein Biomarkers
  • Philips to Introduce Digital Pathology Technology
  • BioImagene Launches Digital Pathology Solutions in Europe
  • BioImagene Unveils Next Generation Virtuoso™ and iScan Coreo Au Slide Scanner
  • Definiens Develops Novel Software Application
  • MikroScan Technologies Unveils New Product Range
  • Aperio Technologies Unveils Discover Your Path Assessment Program for Hospitals
  • CBLPath Introduces Best Practice™ Partnership Program
  • Nikon Instruments Launches Mi Macro Imaging Grossing Station
  • Definiens Introduces Definiens Tissue Studio
  • BioImagene Introduces Crescendo DPW
  • Aperio Technologies Introduces Clinical Partner Service Program
  • Targeted Molecular Diagnostics Introduces Digital Pathology Services in China
  • Applied Spectral Imaging Launches PathEx Duo Detection System
  • Aperio Technologies Launches Digital IHC Solution
  • Visuvi and BioImagene Launch PathSearch™
  • Amirsys Integrates PathIQ ImmunoQuery with Virtuoso of BioImagene

6. RECENT INDUSTRY ACTIVITY

  • Leica Biosystems Takes Over Aperio Technologies
  • Carl Zeiss MicroImaging and Olympus America Sign Licensing Agreement
  • Aperio Technologies and Dell Enter into Strategic Collaboration
  • Erasmus MC Selects Philips to Adopt Digital Pathology System
  • Leica Microsystems and Indica Labs Sign Agreement
  • Ventana Medical Systems Obtains USFDA 510(k) Clearance for VENTANA Companion Algorithm Ki-67 (30-9) Image Analysis Solution
  • AccelPath Acquires DigiPath Solutions
  • Omnyx™ Receives CE Mark in Europe
  • XStor Systems and Quorum Technologies Enter Into Distribution Partnership
  • Royal Philips Electronics and NEC Ink Agreement
  • GE Healthcare Enters into Partnership with Singapore General Hospital
  • PathXL Enters into Partnership with Visiopharm
  • Aperio Technologies Enters into Partnership with Definiens to Market Definiens Tissue Studio™
  • Caliper Life Sciences Takes Over CRi
  • Ventana Medical Systems Takes Over BioImagene
  • Leica Microsystems Acquires Genetix
  • Dartmouth-Hitchcock Medical Center to Deploy BioImagene Solutions
  • Royal Philips Electronics Ink Cooperation Agreement with Definiens
  • UPMC and GE Healthcare Enter into Joint Venture
  • i-Path Diagnostics and iSOFT Group to Enter into Partnership
  • KUMC and BioImagene Enter into Collaboration
  • CRi and 3DHISTECH Ink Exclusive Agreements
  • BioImagene and LigoLab Develop New Interface
  • Olympus America and Omnyx Ink Nonexclusive Global Licensing Agreement
  • Aperio Technologies and ADCIS Enter into Partnership
  • VMscope and Pixcelldata Enter into Partnership
  • Aperio Technologies Receives Patent from United States Patent and Trademark Office
  • Royal Philips Electronics and Dako Ink Agreement
  • Dako Signs Agreement with Omnyx
  • Flagship Biosciences Inks Service Partnership with Expression Pathology
  • Flagship Biosciences Establishes Digital Pathology office in Boston Suburbs
  • Omnyx to Commence Clinical Research Testing of Omnyx Integrated Digital Pathology Solution
  • Henry Ford Health System to Deploy PathPACS® of Apollo PACS
  • Genetix Takes Over SlidePath
  • Omnyx Receives Patent from US Patent and Trademark Office

7. FOCUS ON SELECT GLOBAL PLAYERS

  • 3DHISTECH Ltd. (Hungary)
  • AccelPath, Inc. (US)
  • Apollo PACS, Inc. (US)
  • Carl Zeiss MicroImaging GmbH (Germany)
  • Corista LLC (US)
  • Definiens AG (Germany)
  • DigiPath Inc. (US)
  • Flagship Biosciences, LLC (US)
  • Koninklijke Philips Electronics N.V. (Netherlands)
  • Leica Microsystems GmbH (Germany)
  • Aperio Technologies, Inc. (US)
  • MikroScan Technologies, Inc. (US)
  • Olympus America, Inc. (US)
  • Omnyx, LLC (US)
  • Pixcelldata Ltd. (Ireland)
  • Ventana Medical Systems, Inc. (US)
  • BioImagene, Inc. (US)
  • VMscope GmbH (Germany)

8. GLOBAL MARKET PERSPECTIVE

    • Table 2: World Recent Past, Current and Future Analysis for Digital Pathology Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 3: World Historic Review for Digital Pathology Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 4: World 15-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2004, 2012, and 2018 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • Regulatory Scenario in the US
      • Health Insurance Portability and Accountability Act (HIPAA)
      • Food and Drug Administration (FDA)
      • Clinical Laboratory Improvement Amendments (CLIA)
    • Product Launches
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 5: US Recent Past, Current and Future Analysis for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 6: US Historic Review for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current & Future Analysis
    • Need for Digital Pathology in Canada
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 7: Canadian Recent Past, Current and Future Analysis for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 8: Canadian Historic Review for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

3. JAPAN

  • Market Analysis
    • Table 9: Japanese Recent Past, Current and Future Analysis for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 10: Japanese Historic Review for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Product Launches
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 11: European Recent Past, Current and Future Analysis for Digital Pathology Systems by Country/Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 12: European Historic Review for Digital Pathology Systems by Country/Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 13: European 15-Year Perspective for Digital Pathology Systems by Country/Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain and Rest of Europe Markets for Years 2004, 2012, and 2018 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Product Launch
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 14: Asia-Pacific Recent Past, Current and Future Analysis for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 15: Asia-Pacific Historic Review for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
.

6. REST OF WORLD

  • A. Market Analysis
    • Current & Future Analysis
    • Product Launch
  • B. Market Analytics
    • Table 16: Rest of World Recent Past, Current and Future Analysis for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 17: Rest of World Historic Review for Digital Pathology Systems with Annual Revenues in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Show More
Pricing